Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 2,080.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 0
  • Market Cap: £4,882.17m
  • RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Riad Mishlawi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: John J. Castellani
Independent Non-Executive Director: Laura Balan Balan
Senior Independent Director: Victoria Hull
Non-Executive Dir: Pat Butler, Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 2,080.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 0
Shares Issued 234.72m
Market Cap £4,882.17m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.05% below the market average91.05% below the market average91.05% below the market average91.05% below the market average91.05% below the market average
47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average
Price Trend
45.29% above the market average45.29% above the market average45.29% above the market average45.29% above the market average45.29% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Income
3.16% below the market average3.16% below the market average3.16% below the market average3.16% below the market average3.16% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
33.65% above the market average33.65% above the market average33.65% above the market average33.65% above the market average33.65% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page